NCT03878524 2024-03-04Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME TrialOHSU Knight Cancer InstitutePhase 1 Terminated2 enrolled
NCT01739309 2023-09-21Study of LY2835219 for Mantle Cell LymphomaEli Lilly and CompanyPhase 2 Completed28 enrolled 20 charts
NCT01655225 2022-04-08A Study of LY3023414 in Participants With Advanced CancerEli Lilly and CompanyPhase 1 Completed156 enrolled
NCT02014129 2020-08-24A Study of LY2835219 in Japanese Participants With Advanced CancerEli Lilly and CompanyPhase 1 Completed12 enrolled 11 charts